INDIANAPOLIS, April 19 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company today declared a dividend for the second quarter of 2010 of $0.49 a share on outstanding common stock.
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY
Photo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
PRN Photo Desk, photodesk@prnewswire.comEli Lilly and Company
